Samira Sakhia

Samira Sakhia is President, Chief Executive Officer & Director at Knight Therapeutics, Inc. since 2021.
Chairperson at Biotoscana Investments SA since 2019.
Independent Director at Dollarama, Inc. since 2021.
Secretary, Director & Vice President at Labopharm USA, Inc. since 2014.
Independent Director at Centre universitaire de santé McGill.
Director at Montreal Society For The Prevention of Cruelty To Animals.
Member of the Governors Board at McGill University.
Formerly Director at Nuvo Pharmaceuticals, Inc. from 2015 to 2017.
Director at Labopharm, Inc. Director at ViRexx Medical Corp.
Director at Allon Therapeutics, Inc. Independent Director at Antibe Therapeutics, Inc. from 2014 to 2018.
Independent Director at Profound Medical Corp.
from 2017 to 2019.
Independent Director at Crescita Therapeutics, Inc. from 2016 to 2019.
Controller-North American Operations at Discreet Logic, Inc. Chief Financial Officer & Head-Investor Relations at Paladin Labs, Inc. from 2012 to 2015.
Auditor at Arthur Andersen LLP.
Educated at McGill University with an undergraduate degree and an MBA.